Swiss National Bank
INBX

Swiss National Bank’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Swiss National Bank’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-42,000
Closed -$1.47M – 2546
2024
Q1 		$1.47M Buy
42,000
+3,300
+9% +$120K ﹤0.01% 2010
2023
Q4 		$1.47M Sell
38,700
-18,900
-33% -$405K ﹤0.01% 2018
2023
Q3 		$1.06M Buy
57,600
+1,200
+2% +$25.1K ﹤0.01% 2215
2023
Q2 		$1.46M Hold
56,400
– – ﹤0.01% 2088
2023
Q1 		$1.06M Sell
56,400
-200
-0.4% -$4.65K ﹤0.01% 2218
2022
Q4 		$1.39M Buy
56,600
+1,100
+2% +$32.3K ﹤0.01% 2134
2022
Q3 		$996K Buy
55,500
+1,900
+4% +$34.3K ﹤0.01% 2340
2022
Q2 		$608K Buy
53,600
+31,100
+138% +$458K ﹤0.01% 2563
2022
Q1 		$501K Buy
22,500
+1,200
+6% +$30.6K ﹤0.01% 2605
2021
Q4 		$930K Hold
21,300
– – ﹤0.01% 2506
2021
Q3 		$710K Hold
21,300
– – ﹤0.01% 2519
2021
Q2 		$586K Hold
21,300
– – ﹤0.01% 2609
2021
Q1 		$427K Hold
21,300
– – ﹤0.01% 2466
2020
Q4 		$702K Buy
+21,300
New +$567K ﹤0.01% 2411

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Swiss National Bank's INBX Position: Q2 2024 in Review

Swiss National Bank sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 42,000 shares — an estimated $1.47M sold.

Swiss National Bank first reported a position in INBX in Q4 2020 and held it in 14 quarters. The position peaked at $1.47M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Swiss National Bank reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Swiss National Bank sold 42,000 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $1.47M.
  • Swiss National Bank first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 14 quarters.
  • Swiss National Bank's Inhibrx, Inc. Common Stock position peaked at $1.47M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Swiss National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.